Overexpression of MDA-7/IL-24 as an anticancer cytokine in gene therapy of thyroid carcinoma

被引：17
|
作者：
Mirzaei, Mehri Hajikhan [1 ]
Esmaeilzadeh, Abdolreza [2 ,3 ]
机构：
[1] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genom, Tokyo, Japan
[2] Zanjan Univ Med Sci, Fac Med, Dept Immunol, Zanjan, Iran
[3] Zanjan Univ Med Sci, Fac Med, Canc Gene Therapy Res Ctr, Zanjan, Iran
来源：
JOURNAL OF MEDICAL HYPOTHESES AND IDEAS | 2014年 / 8卷 / 01期
关键词：
Thyroid carcinoma; MDA-7/IL-24; Xenograft mouse model; HTori cell; Immune gene therapy;
D O I：
10.1016/j.jmhi.2013.06.002
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The annual incidence of thyroid cancer worldwide is alarming. Despite current various treatments such as surgical resection, radioiodine therapy and chemotherapy/radiotherapy, thyroid carcinoma remains a lethal cancer. Assuredly, the operative and new treatment strategies are necessary to control this malignancy. Gene therapy is regarded as one of the most reliable novel therapeutic methods for hopeless cases of thyroid cancer and those who do not respond to the prevalent treatments. Accumulated evidence suggests that interleukin-24 (IL-24), also known as melanoma differentiation-associated gene-7, has very important roles in regulation of cell differentiation, cell growth and apoptosis, and it is also a promising anticancer agent. Here, we propose that it could be advantageous to evaluate the anti-tumoural effect of IL-24 in a mouse xenograft model of thyroid cancer. (C) 2013 Tehran University of Medical Sciences. Published by Elsevier Ltd.
引用
收藏
页码：7 / 13
页数：7
相关论文
共 50 条
  • [21] MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 Family
    Chada, S
    Sutton, RB
    Ekmekcioglu, S
    Ellerhorst, J
    Mumm, JB
    Leitner, WW
    Yang, HY
    Sahin, AA
    Hunt, KK
    Fuson, KL
    Poìndexter, N
    Roth, JA
    Ramesh, R
    Grimm, EA
    Mhashilkar, AM
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (05) : 649 - 667
  • [22] Unique aspects of mda-7/IL-24 antitumor bystander activity:: establishing a role for secretion of MDA-7/IL-24 protein by normal cells
    Su, ZZ
    Emdad, L
    Sauane, M
    Lebedeva, IV
    Sarkar, D
    Gupta, P
    James, CD
    Randolph, A
    Valerie, K
    Walter, MR
    Dent, P
    Fisher, PB
    ONCOGENE, 2005, 24 (51) : 7552 - 7566
  • [23] MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo
    Began Gopalan
    Manish Shanker
    Sunil Chada
    Rajagopal Ramesh
    Molecular Cancer, 6
  • [24] mda-7/IL-24:: Multifunctional cancer-specific apoptosis-inducing cytokine
    Gupta, Pankaj
    Su, Zao-zhong
    Lebedeva, Irina V.
    Sarkar, Devanand
    Sauane, Moira
    Emdad, Luni
    Bachelor, Michael A.
    Grant, Steven
    Curiel, David T.
    Dent, Paul
    Fisher, Paul B.
    PHARMACOLOGY & THERAPEUTICS, 2006, 111 (03) : 596 - 628
  • [25] MDA-7/IL-24 inhibits cell survival by inducing apoptosis in nasopharyngeal carcinoma
    Lin, Cheng
    Liu, Haibin
    Li, Li
    Zhu, Qiubei
    Liu, Huanhai
    Ji, Zhenghua
    Liao, Jianchun
    Lang, Juntian
    Wu, Jian
    Fan, Jingping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (11): : 4082 - 4090
  • [26] MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo
    Gopalan, Began
    Shanker, Manish
    Chada, Sunil
    Ramesh, Rajagopal
    MOLECULAR CANCER, 2007, 6 (1)
  • [27] The multifunctional mda-7 gene encodes both tumor suppressor and TH1 cytokine (IL-24) activities
    Chada, S
    Mhashilkar, AM
    Mumm, J
    Caudall, E
    Ekmekcioglu, S
    Poindexter, N
    Sieger, K
    Stewart, A
    Grimm, EA
    CANCER GENE THERAPY, 2003, 10 : S3 - S3
  • [28] mda-7/IL-24:: Exploiting cancer's Achilles' heel
    Lebedeva, IV
    Sauane, M
    Gopalkrishnan, RV
    Sarkar, D
    Su, ZZ
    Gupta, P
    Nemunaitis, J
    Cunningham, C
    Yacoub, A
    Dent, P
    Fisher, PB
    MOLECULAR THERAPY, 2005, 11 (01) : 4 - 18
  • [29] MDA-7/IL-24 as a cancer therapeutic: from bench to bedside
    Dent, Paul
    Yacoub, Adly
    Hamed, Hossein A.
    Park, Margaret A.
    Dash, Rupesh
    Bhutia, Sujit K.
    Sarkar, Devanand
    Gupta, Pankaj
    Emdad, Luni
    Lebedeva, Irina V.
    Sauane, Moira
    Su, Zhao-Zhong
    Rahmani, Mohamed
    Broaddus, William C.
    Young, Harold F.
    Lesniak, Maciej
    Grant, Steven
    Curiel, David T.
    Fisher, Paul B.
    ANTI-CANCER DRUGS, 2010, 21 (08) : 725 - 731
  • [30] MDA-7/interleukin 24 (IL-24) in tumor gene therapy: application of tumor penetrating/homing peptides for improvement of the effects
    Rasoolian, Mohammad
    Kheirollahi, Majid
    Hosseini, Seyed Younes
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) : 211 - 223
12345